ESMO Breast Cancer 2023 KEYNOTE-355 Trial: Outcomes in TNBC Patients Who Discontinued Chemo Before Pembro and in Patients With Immune-Mediated AEs
By
ESMO Breast Cancer 2023 Congress Coverage
FEATURING
Hope Rugo
May 25, 2023
Login to view comments.
Click here to Login